Literature DB >> 23562134

Improvement of cardiac stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional cardiac function.

Sokichi Kamata1, Shigeru Miyagawa, Satsuki Fukushima, Satoshi Nakatani, Atsuhiko Kawamoto, Atsuhiro Saito, Akima Harada, Tatsuya Shimizu, Takashi Daimon, Teruo Okano, Takayuki Asahara, Yoshiki Sawa.   

Abstract

The transplantation of cardiac stem cell sheets (CSC sheets) is a promising therapeutic strategy for ischemic cardiomyopathy, although potential ischemia in the transplanted area remains a problem. Injected endothelial progenitor cells (EPCs) can reportedly induce angiogenesis in the injected area. We hypothesized that concomitant CSC sheet transplantation and EPC injection might show better therapeutic effects for chronic ischemic injury model than the transplantation of CSC sheets alone. Scaffold-free CSC sheets were generated from human c-kit-positive heart-derived cells. A porcine chronic ischemic injury model was generated by placing an ameroid constrictor around the left coronary artery for 4 weeks. The animals then underwent a sham operation, epicardial transplantation of CSC sheet over the ischemic area, intramyocardial injection of EPCs into the ischemic and peri-ischemic area, or CSC sheet transplantation plus EPC injection. The efficacy of each treatment was then assessed for 2 months. Speckle-tracking echocardiography was used to dissect the layer-specific regional systolic function by measuring the radial strain (RS). The epicardial RS in the ischemic area was similarly greater after treatment with the CSC-derived cell sheets alone (19 ± 5%) or in combination with EPC injection (20 ± 5%) compared with the EPC only (9 ± 4%) or sham (7 ± 1%) treatment. The endocardial RS in the ischemic area was greatest after the combined treatment (14 ± 1%), followed by EPC only (12 ± 1%), compared to the CSC only (11 ± 1%) and sham (9 ± 1%) treatments. Consistently, either epicardial CSC sheet implantation or intramyocardial EPC injection yielded increased capillary number and reduced cardiac fibrosis in the ischemic epicardium or endocardium, respectively. Concomitant EPC injection induced the migration of transplanted CSCs into the host myocardium, leading to further neovascularization and reduced fibrosis in the ischemic endocardium, compared to the CSC sole therapy. Transplantation of CSC sheets induced significant functional recovery of the ischemic epicardium, and concomitant EPC transplantation elicited transmural improvement in chronic ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562134     DOI: 10.3727/096368913X665602

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  8 in total

1.  Application of the cell sheet technique in tissue engineering.

Authors:  Guangnan Chen; Yiying Qi; Lie Niu; Tuoyu DI; Jinwei Zhong; Tingting Fang; Weiqi Yan
Journal:  Biomed Rep       Date:  2015-09-29

Review 2.  Engineering Functional Cardiac Tissues for Regenerative Medicine Applications.

Authors:  Martin L Tomov; Carmen J Gil; Alexander Cetnar; Andrea S Theus; Bryanna J Lima; Joy E Nish; Holly D Bauser-Heaton; Vahid Serpooshan
Journal:  Curr Cardiol Rep       Date:  2019-08-01       Impact factor: 2.931

3.  After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.

Authors:  Roberto Bolli; Xian-Liang Tang; Yiru Guo; Qianghong Li
Journal:  Can J Physiol Pharmacol       Date:  2020-09-16       Impact factor: 2.273

4.  Effect of intravenous cell therapy in rats with old myocardial infarction.

Authors:  Xian-Liang Tang; Marcin Wysoczynski; Anna M Gumpert; Yan Li; Wen-Jian Wu; Hong Li; Heather Stowers; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-11-16       Impact factor: 3.396

5.  Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data.

Authors:  Laura Fields; Tomoya Ito; Kazuya Kobayashi; Yuki Ichihara; Mihai-Nicolae Podaru; Mohsin Hussain; Kizuku Yamashita; Vanessa Machado; Fiona Lewis-McDougall; Ken Suzuki
Journal:  Mol Ther       Date:  2021-04-20       Impact factor: 12.910

Review 6.  Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide.

Authors:  Olivier Schussler; Pierre E Falcoz; Juan C Chachques; Marco Alifano; Yves Lecarpentier
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 7.  Present and future perspectives on cell sheet-based myocardial regeneration therapy.

Authors:  Yoshiki Sawa; Shigeru Miyagawa
Journal:  Biomed Res Int       Date:  2013-12-04       Impact factor: 3.411

Review 8.  The State of Art of Regenerative Therapy in Cardiovascular Ischemic Disease: Biology, Signaling Pathways, and Epigenetics of Endothelial Progenitor Cells.

Authors:  Fabio Perrotta; Angelica Perna; Klara Komici; Ersilia Nigro; Mariano Mollica; Vito D'Agnano; Antonio De Luca; Germano Guerra
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.